Countdown to 2021 CBIIC:


Head of Research and Development of I-Mab Biopharma Co., Ltd.

Joan Huaqiong Shen, M.D., Ph.D., is a US Board-certified physician and holds a PhD in life sciences from Indiana University School of Medicine where she had fellowship trainings in endocrinology, psychopharmacology and clinical pharmacology and where she and was appointed as an adjunctive professor in the department of psychiatry.

Dr. Shen serves in many executive positions in Eli Lilly &Company, Wyeth, Pfizer, Hengrui and Johnson & Johnson. In Hengrui, she built the largest clinical team among domestic pharma companies and led successful trials in China, US and Australia. At Johnson & Johnson, She oversaw all clinical development programs in China. Dr. Shen joined I-Mab biopharma as the head of R&D in 2017.

Dr. Shen was elected for the co-chair of RDPAC’s R&D core team and was granted the honor of “Talent of Innovation” by the “National Thousand Talent Program”. She sits in the executive committee of China New Drug Research Evaluation Committee. She also holds academic positions as the guest professor of Beijing University Clinical Research Institute.